Kaveh Bagheri, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 8860 Center Drive, Suite 240, La Mesa, CA 91942 Phone: 619-589-2535 Fax: 619-589-8042 |
Mehran Mandegar, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 5555 Grossmont Center Dr, La Mesa, CA 91942 Phone: 888-664-8297 Fax: 801-650-6861 |
Dr. Ashish Tulsidas Agrawal, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 5555 Grossmont Center Dr, La Mesa, CA 91942 Phone: 888-664-8297 Fax: 619-342-2655 |
Oleg Yuryevich Sorokoumov, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 5555 Grossmont Center Dr, Sharp Grossmont Hospital, La Mesa, CA 91942 Phone: 858-248-3634 |
Dr. Larry Newell Ayers, MD Internal Medicine - Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 5565 Grossmont Center Dr, Ste 360, La Mesa, CA 91942 Phone: 619-462-3360 Fax: 619-462-3363 |
News Archive
Cell Therapeutics, Inc. today announced the initiation of an international cooperative group Phase 2 clinical trial of pacritinib in adult patients with relapsed acute myeloid leukemia (AML) with mutations of the FLT3 gene. Mutation of the FLT3 gene is found in approximately one-third of AML patients and is an independent risk factor for poor prognosis.
Social inequalities such as inadequate education, a lack of human rights, poverty and poor housing negatively can impact global health conditions, according to a report released Thursday by the World Health Organization's Commission on the Social Determinants of Health, Toronto's Globe and Mail reports.
NMT Medical today announced a favorable decision by the U.S. Patent and Trademark Office Board of Appeals relating to the Company's patent infringement actions against AGA Medical Corp.
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
› Verified 3 days ago